Can the epinephrine in intra‑articular pain injections cause skin necrosis and wound breakdown after total knee arthroplasty?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Epinephrine in Intra-articular Injections and Wound Complications After TKA

Stop using epinephrine in your intra-articular pain injections for total knee arthroplasty—it provides no analgesic benefit and carries a well-documented risk of tissue necrosis.

The Evidence Against Epinephrine

Guideline Recommendations Are Clear

Adjuvant peripheral nerve drugs such as alpha-2-adrenoceptor agonists (clonidine, epinephrine) are not recommended because of lack of efficacy in procedure-specific studies for total knee arthroplasty 1. This comes from the PROSPECT Working Group's comprehensive systematic review specifically addressing TKA analgesia 1.

The 2019 French Society of Anaesthesia guidelines similarly recommend against exceeding maximal toxic doses of local anesthetics, particularly for peri-prosthetic orthopedic infiltrations, and explicitly state concerns about tissue toxicity 2.

Direct Evidence of Harm

The FDA drug label for epinephrine contains explicit warnings that are directly relevant to your clinical scenario:

  • "Do not administer repeated injections of epinephrine at the same site, as the resulting vasoconstriction may cause tissue necrosis" 3
  • "Epinephrine is a strong vasoconstrictor. Accidental injection into the digits, hands or feet may result in loss of blood flow to the affected area and has been associated with tissue necrosis" 3
  • Rare cases of serious skin and soft tissue infections, including necrotizing fasciitis and myonecrosis caused by Clostridia (gas gangrene), have been reported at the injection site following epinephrine injection 3

Clinical Trial Data Confirms No Benefit

A 2017 prospective, randomized, double-blind controlled trial directly tested whether adding adrenaline to ropivacaine in local infiltration analgesia (LIA) provided any advantage 4. The results were definitive:

  • No difference in VAS pain scores before or after first mobilization 4
  • No difference in pain scores over the first 48 hours postoperatively 4
  • No difference in rescue medication requirements, early mobilization, or length of hospital stay 4

The authors concluded: "To prevent possible negative side effects (e.g. tissue necrosis), adrenaline should be omitted from the LIA mixture" 4.

Mechanism of Tissue Damage

Vasoconstriction-Induced Necrosis

Animal studies demonstrate dose-dependent tissue necrosis from epinephrine:

  • Lidocaine with epinephrine in concentrations of 1:100,000 and 1:200,000 showed significantly higher necrosis rates in rat skin flaps compared to controls 5
  • Only concentrations of 1:400,000 and 1:800,000 were found safe for skin flap survival 5

Synergistic Effects with Surgical Stress

Recent research reveals that stress-stimulated epinephrine induces premature senescence in dermal fibroblasts and contributes to impaired skin wound healing 6. This is particularly relevant in the surgical setting where:

  • Epinephrine promotes expression of senescence markers and pro-inflammatory cytokines in human dermal fibroblasts 6
  • Epinephrine administration impairs wound closure in both young and aged human skin 6

Historical Context

The necrotizing potential of epinephrine has been recognized since 1956, when studies showed that as little as 5 micrograms of intradermal epinephrine combined with endotoxin produced extensive dermal hemorrhagic necrosis 7. The surgical environment, with its inflammatory milieu, may create similar conditions.

What You Should Do Instead

Recommended Analgesic Approach

Based on the PROSPECT guidelines for TKA 1:

  • Femoral nerve block (Grade A recommendation) for primary analgesia 1
  • Alternatively, spinal anesthesia with local anesthetic plus spinal morphine 1
  • Supplemental multimodal analgesia: paracetamol + conventional NSAID or COX-2 inhibitors 1
  • Intravenous strong opioids for breakthrough high-intensity pain 1

If Using Local Infiltration Analgesia

Use ropivacaine alone without epinephrine 4. The 2017 trial demonstrated that single-shot LIA with ropivacaine (2% in 150 mL volume) provides clinically acceptable pain control without the tissue necrosis risk 4.

A 2025 review confirmed that periarticular multimodal drug injection can include ropivacaine with dexamethasone, but notably, when epinephrine was included in combinations, no superiority was demonstrated 8.

Critical Safety Considerations

Avoid Intra-articular Catheters

Do not perform analgesic infiltration using an intra-articular catheter because of the toxic risk of local anesthetics on cartilage 2. Published studies suggest direct toxicity of local anesthetics on chondrocytes 2.

Monitor for Infection

Given the FDA warnings about Clostridial infections 3, advise patients to seek immediate medical care if they develop:

  • Persistent redness, warmth, swelling, or tenderness at the injection site 3
  • Any signs suggesting necrotizing fasciitis or gas gangrene 3

The "Epinephrine Myth" Persists

A 2024 comprehensive review acknowledged that while epinephrine use in acral areas has been reconsidered, the risk of necrosis cannot be entirely eliminated, particularly in patients with compromised vascular function 9. The perioperative TKA setting, with tourniquet use and surgical trauma, represents exactly such a compromised vascular state.

Bottom Line

Your clinical observation of skin necrosis and wound breakdown is consistent with the known vasoconstrictive and tissue-damaging effects of epinephrine. The evidence shows no analgesic benefit from adding epinephrine to local infiltration analgesia in TKA, while multiple sources document tissue necrosis risk. Eliminate epinephrine from your pain injection protocol immediately 1, 3, 4.

Related Questions

In an older adult undergoing primary total knee arthroplasty without renal impairment, peptic ulcer disease, or medication allergies, what is the recommended sequence for adding agents to the peri‑articular injection mixture?
Is a cortisone (corticosteroid) intra‑articular knee injection contraindicated in a patient with atrial flutter?
Is a knee intra‑articular steroid injection contraindicated in a patient with a Lyme disease‑related joint effusion?
How should a combined intra‑articular lidocaine and depot corticosteroid injection be performed for knee pain, including dosage, technique, frequency, and safety precautions?
What is the recommended composition and dosing of a peri‑articular multimodal injection containing bupivacaine, fentanyl, and tranexamic acid for analgesia in total knee arthroplasty?
How should overtraining syndrome be managed in athletes?
Is it safe to administer a vitamin B12 (cobalamin) injection to a patient receiving paclitaxel (Taxol) chemotherapy and concurrent radiation therapy?
What is Peridex (chlorhexidine gluconate oral rinse) used for?
What is the appropriate management of a patient with Mycoplasma pneumoniae infection presenting with Fuchs syndrome (mucosal‑only Stevens–Johnson syndrome) affecting the respiratory system?
What oral antibiotic and treatment duration is optimal for an elderly male (>80 years) with a chronic indwelling urinary catheter, a positive urine analysis, impaired renal function (estimated GFR ~42 mL/min), and a Vioxx allergy?
Can a 60 mg dose of dextromethorphan be given safely?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.